FY2026 Update: A new code, E11.A (Type 2 diabetes mellitus in remission), was introduced effective October 1, 2025
Kidney function The SELECT trial produced an important secondary finding: semaglutide reduced the 5-component kidney composite endpoint by 22% compared to placebo
Rita Kapoor help patients understand what to expect from semaglutide GLP-1 therapy and guides them through a personalized weight management plan
To help with that clarity, MeAgain's GLP-1 app offers clear explanations, easy tracking, and personalized insights so you can watch how semaglutide, food, and activity affect insulin sensitivity, mood, and overall hormone balance
When to Start the New Medication After Your Last Dose General rule